![Louis Tamayo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Louis Tamayo
Director of Finance/CFO at
LEXEO THERAPEUTICS, INC.
Net worth: 383 706 $ as of 31/07/2026
Profile
Louis Tamayo is Chief Financial Officer at Lexeo Therapeutics, Inc. since 2025.
Formerly, Mr. Tamayo was Senior Vice President – Operational Excellence at Siemens Healthineers AG from 2023 to 2024.
Education includes an undergraduate degree from Northeastern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/08/2026 | 92,907 ( 0.12% ) | 383 706 $ | 31/07/2026 |
Louis Tamayo active positions
| Companies | Position | Start |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Director of Finance/CFO | 15/08/2025 |
Former positions of Louis Tamayo
| Companies | Position | End |
|---|---|---|
| SIEMENS HEALTHINEERS AG | Corporate Officer/Principal | 01/10/2024 |
Training of Louis Tamayo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Siemens Healthineers AG
 Siemens Healthineers AG Medical SpecialtiesHealth Technology Provides diagnostic imaging and computer related services | Health Technology |
Lexeo Therapeutics Inc
 Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
- Stock Market
- Insiders
- Louis Tamayo
